KIM HWAN MOOK,JEONG KEUN YEONG,SIM JAE JUN,JANG YEONG SU
申请号：
IN201747026303
公开号：
IN201747026303A
申请日:
2017.07.25
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention relates to: a pharmaceutical composition for treating cancer containing as an active ingredient a lactate metal salt which can be dissociated in cancer cells into lactate capable of effectively inhibiting actions such as proliferation invasion and metastasis of cancer cells by disturbing the metabolic processes of cancer cells； a pharmaceutical composition for inhibiting cancer metastasis； a food composition for alleviating cancer； and a method for treating cancer and a method for inhibiting cancer metastasis both methods comprising a step of administering the lactate metal salt. The lactate metal salt of the present invention inhibits the growth of cancer cells and induces the death of cancer cells by disturbing the metabolic processes in the main energy production pathways of cancer and inhibits the expression of factors inducing resistance against radiation exposure while having no side effects. Therefore the lactate metal salt can be widely utilized in a more effective anti cancer therapy.
